Search - tctmd.com

Displaying 381 - 400 of 1574

Sort: Relevancy | Date

Presentation TCT 2022

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Presenter: Rania Hammami

September 19, 2022

Presentation TCT 2022

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Presenter: Navin Kapur

September 19, 2022

Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2022

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

Presenter: Daniel Jones

September 19, 2022

Presentation TCT 2022

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

Presenter: Jung-Min Ahn

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Presenter: Tijn Jansen

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Presenter: Charles J. Davidson

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Presenter: John Carroll

September 18, 2022

Presentation TCT 2022

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Presenter: Patrick O'Gara

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Presenter: Mahmoud Khalil

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

$TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial$

Presentation TCT 2022

TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial

Presenter: Patrick Serruys

September 18, 2022

Advertisement

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content